New Quality Indicator Set for Systemic Sclerosis

Update: 2014-03-26

Description

Leading rheumatologists from around the world have released a new set of quality indicators for Systemic Sclerosis. These guidelines will help ensure the best measure of disease progression and control of associated conditions, like pulmonary hypertension. Quality indicators are an important part of treating any disease and help advance patient care by developing a better understanding of the healthcare process.

Comments

In Channel

Diuretics in PAH

2014-05-1449:55

Working with Social Workers to Enhance the PH Team

2014-05-0748:07

The Role of the Respiratory Therapist in the Treatment of Pulmonary Hypertension Patients

2014-04-3058:41

Understanding Compassion Fatigue

2014-04-2331:14

The Treatment of Pulmonary Arterial Hypertension with the Anti-proliferative Agent Hydroxyurea

2014-04-0928:08

Pulmonary Hypertension in Schistosomiasis: An Overview

2014-04-0201:09:49

New Quality Indicator Set for Systemic Sclerosis

2014-03-2632:19

Design and Validation of a Novel EPC Microfluidic Capture Chip and its Application in Patients with PAH

2014-03-1942:05

Caveolin-1 Expression During the Progression of Pulmonary Hypertension

2013-11-1135:09

17-Beta Estradiol Attenuates Hypoxic Pulmonary Hypertension via Estrogen Receptor-mediated Effects

2013-11-1049:58

00:00

New Quality Indicator Set for Systemic Sclerosis

#box-pro-ellipsis-176131939246188{-webkit-line-clamp:2;}New Quality Indicator Set for Systemic Sclerosis

New Quality Indicator Set for Systemic Sclerosis

Daniel Furst, MD

New Quality Indicator Set for Systemic Sclerosis